BioAge Labs, Inc.
BIOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,054 | $2,412 | $1,451 | $0 |
| % Growth | -14.8% | 66.2% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2,054 | $2,412 | $1,451 | $0 |
| % Margin | 100% | 100% | 100% | – |
| R&D Expenses | $18,513 | $19,844 | $11,109 | $19,225 |
| G&A Expenses | $6,681 | $7,339 | $6,788 | $6,137 |
| SG&A Expenses | $6,681 | $7,339 | $6,788 | $6,137 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25,194 | $27,183 | $17,897 | $25,362 |
| Operating Income | -$23,140 | -$24,771 | -$16,446 | -$25,362 |
| % Margin | -1,126.6% | -1,027% | -1,133.4% | – |
| Other Income/Exp. Net | $2,969 | $3,208 | $3,518 | $4,233 |
| Pre-Tax Income | -$20,171 | -$21,563 | -$12,928 | -$21,129 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20,171 | -$21,563 | -$12,928 | -$21,129 |
| % Margin | -982% | -894% | -891% | – |
| EPS | -0.56 | -0.6 | -0.36 | -1.97 |
| % Growth | 6.7% | -66.7% | 81.7% | – |
| EPS Diluted | -0.56 | -0.6 | -0.36 | -1.97 |
| Weighted Avg Shares Out | 35,850 | 35,850 | 35,850 | 35,850 |
| Weighted Avg Shares Out Dil | 35,850 | 35,850 | 35,850 | 35,850 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,160 | $3,420 | $3,714 | $4,095 |
| Interest Expense | $149 | $201 | $255 | $319 |
| Depreciation & Amortization | $49 | $58 | $37 | $47 |
| EBITDA | -$19,973 | -$21,304 | -$12,636 | -$20,763 |
| % Margin | -972.4% | -883.3% | -870.8% | – |